Abstract
This overview provides a brief review of the 2023 American Heart Association, American College of Cardiology, American College of Clinical Pharmacy, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association guideline for the management of patients with chronic coronary disease. Clinical recommendations with a focus on a team-based approach, lifestyle modification, risk stratification, diagnostic testing, and pharmacologic and nonpharmacologic management are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 26-33 |
| Number of pages | 8 |
| Journal | Nurse Practitioner |
| Volume | 50 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1 2025 |
Bibliographical note
Publisher Copyright:© 2025 Wolters Kluwer Health, Inc. All rights reserved.
Keywords
- American College of Cardiology guidelines
- American Heart Association guidelines
- atherosclerosis
- chronic coronary disease
- coronary artery disease
- diagnostic testing
- nonpharmacologic management
- pharmacologic management
- risk factor stratification
- social determinants of health
ASJC Scopus subject areas
- General Nursing
